1
|
Kazemi N, Abdolrazzaghi M, Light PE, Musilek P. In-human testing of a non-invasive continuous low-energy microwave glucose sensor with advanced machine learning capabilities. Biosens Bioelectron 2023; 241:115668. [PMID: 37774465 DOI: 10.1016/j.bios.2023.115668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2023] [Revised: 07/08/2023] [Accepted: 09/03/2023] [Indexed: 10/01/2023]
Abstract
Continuous glucose monitoring schemes that avoid finger pricking are of utmost importance to enhance the comfort and lifestyle of diabetic patients. To this aim, we propose a microwave planar sensing platform as a potent sensing technology that extends its applications to biomedical analytes. In this paper, a compact planar resonator-based sensor is introduced for noncontact sensing of glucose. Furthermore, in vivo and in-vitro tests using a microfluidic channel system and in clinical trial settings demonstrate its reliable operation. The proposed sensor offers real-time response and a high linear correlation (R2 ∼ 0.913) between the measured sensor response and the blood glucose level (GL). The sensor is also enhanced with machine learning to predict the variation of body glucose levels for non-diabetic and diabetic patients. This addition is instrumental in triggering preemptive measures in cases of unusual glucose level trends. In addition, it allows for the detection of common artifacts of the sensor as anomalies so that they can be removed from the measured data. The proposed system is designed to noninvasively monitor interstitial glucose levels in humans, introducing the opportunity to create a customized wearable apparatus with the ability to learn.
Collapse
Affiliation(s)
- Nazli Kazemi
- Electrical and Computer Engineering, University of Alberta, 116 St., Edmonton, T6G 2R3, AB, Canada.
| | | | - Peter E Light
- Faculty of Medicine and Dentistry Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, 112 St., Edmonton, T6G 2R3, AB, Canada.
| | - Petr Musilek
- Electrical and Computer Engineering, University of Alberta, 116 St., Edmonton, T6G 2R3, AB, Canada; Applied Cybernetics, University of Hradec Králové, Rokitanského 62/26, Hradec Králové, 500 03, Czechia, Czech Republic.
| |
Collapse
|
2
|
Chmayssem A, Nadolska M, Tubbs E, Sadowska K, Vadgma P, Shitanda I, Tsujimura S, Lattach Y, Peacock M, Tingry S, Marinesco S, Mailley P, Lablanche S, Benhamou PY, Zebda A. Insight into continuous glucose monitoring: from medical basics to commercialized devices. Mikrochim Acta 2023; 190:177. [PMID: 37022500 DOI: 10.1007/s00604-023-05743-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Accepted: 03/08/2023] [Indexed: 04/07/2023]
Abstract
According to the latest statistics, more than 537 million people around the world struggle with diabetes and its adverse consequences. As well as acute risks of hypo- or hyper- glycemia, long-term vascular complications may occur, including coronary heart disease or stroke, as well as diabetic nephropathy leading to end-stage disease, neuropathy or retinopathy. Therefore, there is an urgent need to improve diabetes management to reduce the risk of complications but also to improve patient's quality life. The impact of continuous glucose monitoring (CGM) is well recognized, in this regard. The current review aims at introducing the basic principles of glucose sensing, including electrochemical and optical detection, summarizing CGM technology, its requirements, advantages, and disadvantages. The role of CGM systems in the clinical diagnostics/personal testing, difficulties in their utilization, and recommendations are also discussed. In the end, challenges and prospects in future CGM systems are discussed and non-invasive, wearable glucose biosensors are introduced. Though the scope of this review is CGMs and provides information about medical issues and analytical principles, consideration of broader use will be critical in future if the right systems are to be selected for effective diabetes management.
Collapse
Affiliation(s)
- Ayman Chmayssem
- UMR 5525, Univ. Grenoble Alpes, CNRS, Grenoble INP, INSERM, TIMC, VetAgro Sup, 38000, Grenoble, France
| | - Małgorzata Nadolska
- Institute of Nanotechnology and Materials Engineering, Faculty of Applied Physics and Mathematics, Gdansk University of Technology, 80-233, Gdansk, Poland
| | - Emily Tubbs
- Univ. Grenoble Alpes, CEA, INSERM, IRIG, 38000, Grenoble, Biomics, France
- Univ. Grenoble Alpes, LBFA and BEeSy, INSERM, U1055, F-38000, Grenoble, France
| | - Kamila Sadowska
- Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Ks. Trojdena 4, 02-109, Warsaw, Poland
| | - Pankaj Vadgma
- School of Engineering and Materials Science, Queen Mary University of London, Mile End, London, E1 4NS, UK
| | - Isao Shitanda
- Department of Pure and Applied Chemistry, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan
- Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan
| | - Seiya Tsujimura
- Japanese-French lAaboratory for Semiconductor physics and Technology (J-F AST)-CNRS-Université Grenoble Alpes-Grenoble, INP-University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8573, Japan
- Division of Material Science, Faculty of Pure and Applied Science, University of Tsukuba, 1-1-1, Tennodai, Ibaraki, Tsukuba, 305-5358, Japan
| | | | - Martin Peacock
- Zimmer and Peacock, Nedre Vei 8, Bldg 24, 3187, Horten, Norway
| | - Sophie Tingry
- Institut Européen Des Membranes, UMR 5635, IEM, Université Montpellier, ENSCM, CNRS, Montpellier, France
| | - Stéphane Marinesco
- Plate-Forme Technologique BELIV, Lyon Neuroscience Research Center, UMR5292, Inserm U1028, CNRS, Univ. Claude-Bernard-Lyon I, 69675, Lyon 08, France
| | - Pascal Mailley
- Univ. Grenoble Alpes, CEA, LETI, 38000, Grenoble, DTBS, France
| | - Sandrine Lablanche
- Univ. Grenoble Alpes, LBFA and BEeSy, INSERM, U1055, F-38000, Grenoble, France
- Department of Endocrinology, Grenoble University Hospital, Univ. Grenoble Alpes, Pôle DigiDune, Grenoble, France
| | - Pierre Yves Benhamou
- Department of Endocrinology, Grenoble University Hospital, Univ. Grenoble Alpes, Pôle DigiDune, Grenoble, France
| | - Abdelkader Zebda
- UMR 5525, Univ. Grenoble Alpes, CNRS, Grenoble INP, INSERM, TIMC, VetAgro Sup, 38000, Grenoble, France.
- Japanese-French lAaboratory for Semiconductor physics and Technology (J-F AST)-CNRS-Université Grenoble Alpes-Grenoble, INP-University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8573, Japan.
| |
Collapse
|
3
|
Virtual screening and computational simulation analysis of antimicrobial photodynamic therapy using propolis-benzofuran A to control of Monkeypox. Photodiagnosis Photodyn Ther 2023; 41:103208. [PMID: 36417972 PMCID: PMC9675939 DOI: 10.1016/j.pdpdt.2022.103208] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Revised: 11/05/2022] [Accepted: 11/18/2022] [Indexed: 11/21/2022]
Abstract
BACKGROUND Monkeypox is a viral zoonotic disease and there are no available treatments that specifically target the monkeypox virus. Antimicrobial photodynamic therapy (aPDT) is a non-invasive approach that has been introduced as a targeted adjuvant treatment against various microbial infections. In this study, we used a computational strategy to investigate the potential of aPDT using propolis-benzofuran A against the Monkeypox virus. METHODS In this in silico study, the evaluation of drug-likeness, molecular properties, and bioactivity of propolis-benzofuran A was carried out using SwissADME. Pro-Tox II and OSIRIS servers were used to identify the organ toxicities and toxicological endpoints of propolis-benzofuran A. Molecular docking approach was employed to screen the potential binding modes of propolis-benzofuran A ligand with the Monkeypox virus A48R protein (PDB ID: 2V54). RESULTS The results of the computational investigation revealed that propolis-benzofuran A obeyed all the criteria of Lipinski's rule of five and exhibited drug-likeness. The photosensitizing agent tested was categorized as toxicity class-5 and was found to be non-hepatotoxic, non-carcinogenic, non-mutagenic, and non-cytotoxic. The docking studies employing a predicted three-dimensional model of Monkeypox virus A48R protein with propolis-benzofuran A ligand exhibited good binding affinity (-7.84 kcal/mol). DISCUSSION The computational simulation revealed that propolis-benzofuran A had a strong binding affinity with the Monkeypox virus A48R protein. Hence, aPDT based on this natural photosensitizer can be proposed as an adjuvant treatment against the Monkeypox virus.
Collapse
|
4
|
Li MS, Wong HL, Ip YL, Peng Z, Yiu R, Yuan H, Wai Wong JK, Chan YK. Current and Future Perspectives on Microfluidic Tear Analytic Devices. ACS Sens 2022; 7:1300-1314. [PMID: 35579258 DOI: 10.1021/acssensors.2c00569] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Most current invasive analytic devices for disease diagnosis and monitoring require the collection of blood, which causes great discomfort for patients and may potentially cause infection. This explains the great need for noninvasive devices that utilize other bodily fluids like sweat, saliva, tears, or urine. Among them, eye tears are easily accessible, less complex in composition, and less susceptible to dilution. Tears also contain valuable clinical information for the diagnosis of ocular and systemic diseases as the tear analyte level shows great correlation with the blood analyte level. These unique advantages make tears a promising platform for use in clinical settings. As the volume of tear film and the rate of tear flow are only microliters in size, the use of microfluidic technology in analytic devices allows minimal sample consumption. Hence, more and more microfluidic tear analytic devices have been proposed, and their working mechanisms can be broadly categorized into four main types: (a) electrochemical, (b) photonic crystals, (c) fluorescence, and (d) colorimetry. These devices are being developed toward the application of point-of-care tests with rapid yet accurate results. This review aims to provide a general overview of the recent developmental trend of microfluidic devices for tear analysis. Moreover, the fundamental principle behind each type of device along with their strengths and weaknesses will be discussed, especially in terms of their abilities and potential in being used in point-of-care settings.
Collapse
Affiliation(s)
- Man Shek Li
- Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 000000
| | - Ho Lam Wong
- Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 000000
| | - Yan Lam Ip
- Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 000000
| | - Zhiting Peng
- Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 000000
| | - Rachel Yiu
- Department of Ophthalmology, Grantham Hospital, Hong Kong West Cluster, Hong Kong SAR 000000
| | - Hao Yuan
- School of Life Sciences and Engineering, Southwest Jiaotong University, Chengdu, Sichuan 610031, P R China
| | - Jasper Ka Wai Wong
- Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 000000
- Department of Ophthalmology, Grantham Hospital, Hong Kong West Cluster, Hong Kong SAR 000000
| | - Yau Kei Chan
- Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 000000
| |
Collapse
|
5
|
Elsherif M, Moreddu R, Alam F, Salih AE, Ahmed I, Butt H. Wearable Smart Contact Lenses for Continual Glucose Monitoring: A Review. Front Med (Lausanne) 2022; 9:858784. [PMID: 35445050 PMCID: PMC9013844 DOI: 10.3389/fmed.2022.858784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Accepted: 03/10/2022] [Indexed: 11/15/2022] Open
Abstract
Diabetes mellitus is a chronic disease requiring a careful management to prevent its collateral complications, such as cardiovascular and Alzheimer's diseases, retinopathy, nephropathy, foot and hearing impairment, and neuropathy. Self-monitoring of blood glucose at point-of-care settings is an established practice for diabetic patients. However, current technologies for glucose monitoring are invasive, costly, and only provide single snapshots for a widely varying parameter. On the other hand, tears are a source of physiological information that mirror the health state of an individual by expressing different concentrations of metabolites, enzymes, vitamins, salts, and proteins. Therefore, the eyes may be exploited as a sensing site with substantial diagnostic potential. Contact lens sensors represent a viable route for targeting minimally-invasive monitoring of disease onset and progression. Particularly, glucose concentration in tears may be used as a surrogate to estimate blood glucose levels. Extensive research efforts recently have been devoted to develop smart contact lenses for continual glucose detection. The latest advances in the field are reviewed herein. Sensing technologies are described, compared, and the associated challenges are critically discussed.
Collapse
Affiliation(s)
- Mohamed Elsherif
- Department of Mechanical Engineering, Khalifa University of Science and Engineering, Abu Dhabi, United Arab Emirates
- *Correspondence: Mohamed Elsherif
| | | | - Fahad Alam
- Department of Mechanical Engineering, Khalifa University of Science and Engineering, Abu Dhabi, United Arab Emirates
| | - Ahmed E. Salih
- Department of Mechanical Engineering, Khalifa University of Science and Engineering, Abu Dhabi, United Arab Emirates
| | - Israr Ahmed
- Department of Mechanical Engineering, Khalifa University of Science and Engineering, Abu Dhabi, United Arab Emirates
| | - Haider Butt
- Department of Mechanical Engineering, Khalifa University of Science and Engineering, Abu Dhabi, United Arab Emirates
- Haider Butt
| |
Collapse
|
6
|
Elsherif M, Alam F, Salih AE, AlQattan B, Yetisen AK, Butt H. Wearable Bifocal Contact Lens for Continual Glucose Monitoring Integrated with Smartphone Readers. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2021; 17:e2102876. [PMID: 34605152 DOI: 10.1002/smll.202102876] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/17/2021] [Revised: 07/22/2021] [Indexed: 06/13/2023]
Abstract
Commercial implantable continuous glucose monitoring devices are invasive and discomfort. Here, a minimally-invasive glucose detection system is developed to provide quantitative glucose measurements continually based on bifocal contact lenses. A glucose-sensitive phenylboronic acid derivative is immobilized in a hydrogel matrix and the surface of the hydrogel is imprinted with a Fresnel lens. The glucose-responsive hydrogel is attached to a commercial soft contact lens to be transformed into a bifocal contact lens. The contact lens showed bifocal lengths; far-field focal length originated from the contact lens' curvature, and near-field focal length resulting from the Fresnel lens. When tear glucose increased, the refractive index and groove depth of the Fresnel lens changed, shifting the near-field focal length and the light focusing efficiency. The recorded optical signals are detected at an identical distance far from the contact lens change. The bifocal contact lens allowed for detecting the tear glucose concentration within the physiological range of healthy individuals and diabetics (0.0-3.3 mm). The contact lens rapidly responded to glucose concentration changes and reached 90% of equilibrium within 40 min. The bifocal contact lens is a wearable diagnostic platform for continual biomarker detection at point-of-care settings.
Collapse
Affiliation(s)
- Mohamed Elsherif
- Department of Mechanical Engineering, Khalifa University, Abu Dhabi, 127788, UAE
| | - Fahad Alam
- Department of Mechanical Engineering, Khalifa University, Abu Dhabi, 127788, UAE
| | - Ahmed E Salih
- Department of Mechanical Engineering, Khalifa University, Abu Dhabi, 127788, UAE
| | - Bader AlQattan
- Department of Mechanical Engineering, Khalifa University, Abu Dhabi, 127788, UAE
| | - Ali K Yetisen
- Department of Chemical Engineering, Imperial College London, London, SW7 2AZ, UK
| | - Haider Butt
- Department of Mechanical Engineering, Khalifa University, Abu Dhabi, 127788, UAE
| |
Collapse
|
7
|
Dennyson Savariraj A, Salih A, Alam F, Elsherif M, AlQattan B, Khan AA, Yetisen AK, Butt H. Ophthalmic Sensors and Drug Delivery. ACS Sens 2021; 6:2046-2076. [PMID: 34043907 PMCID: PMC8294612 DOI: 10.1021/acssensors.1c00370] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2021] [Accepted: 05/17/2021] [Indexed: 12/15/2022]
Abstract
Advances in multifunctional materials and technologies have allowed contact lenses to serve as wearable devices for continuous monitoring of physiological parameters and delivering drugs for ocular diseases. Since the tear fluids comprise a library of biomarkers, direct measurement of different parameters such as concentration of glucose, urea, proteins, nitrite, and chloride ions, intraocular pressure (IOP), corneal temperature, and pH can be carried out non-invasively using contact lens sensors. Microfluidic contact lens sensor based colorimetric sensing and liquid control mechanisms enable the wearers to perform self-examinations at home using smartphones. Furthermore, drug-laden contact lenses have emerged as delivery platforms using a low dosage of drugs with extended residence time and increased ocular bioavailability. This review provides an overview of contact lenses for ocular diagnostics and drug delivery applications. The designs, working principles, and sensing mechanisms of sensors and drug delivery systems are reviewed. The potential applications of contact lenses in point-of-care diagnostics and personalized medicine, along with the significance of integrating multiplexed sensing units together with drug delivery systems, have also been discussed.
Collapse
Affiliation(s)
| | - Ahmed Salih
- Department
of Mechanical Engineering, Khalifa University
of Science and Technology, Abu Dhabi, United Arab Emirates
| | - Fahad Alam
- Department
of Mechanical Engineering, Khalifa University
of Science and Technology, Abu Dhabi, United Arab Emirates
| | - Mohamed Elsherif
- Department
of Mechanical Engineering, Khalifa University
of Science and Technology, Abu Dhabi, United Arab Emirates
| | - Bader AlQattan
- Department
of Mechanical Engineering, Khalifa University
of Science and Technology, Abu Dhabi, United Arab Emirates
| | - Ammar A. Khan
- Department
of Chemical Engineering, Imperial College
London, London SW7 2AZ, United Kingdom
| | - Ali K. Yetisen
- Department
of Physics, Lahore University of Management
Sciences, Lahore Cantonment 54792, Lahore, Pakistan
| | - Haider Butt
- Department
of Mechanical Engineering, Khalifa University
of Science and Technology, Abu Dhabi, United Arab Emirates
| |
Collapse
|
8
|
Poplinger D, Bokan M, Hesin A, Thankarajan E, Tuchinsky H, Gellerman G, Patsenker L. Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer Cells. Bioconjug Chem 2021; 32:1641-1651. [PMID: 34115936 DOI: 10.1021/acs.bioconjchem.1c00205] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Ratiometric measurements utilizing two independent fluorescence signals from a dual-dye molecular system help to improve the detection sensitivity and quantification of many analytical, bioanalytical, and pharmaceutical assays, including drug delivery monitoring. Nevertheless, these dual-dye conjugates have never been utilized for ratiometric monitoring of antibody (Ab)-guided targeted drug delivery (TDD). Here, we report for the first time on the new, dual-dye TDD system, Cy5s-Ab-Flu-Aza, comprising the switchable fluorescein-based dye (Flu) linked to the anticancer drug azatoxin (Aza), reference pentamethine cyanine dye (Cy5s), and Her2-specific humanized monoclonal Trastuzumab (Herceptin) antibody. The ability of ratiometric fluorescence monitoring of drug release was demonstrated with this model system in vitro in the example of the human breast cancer SKBR3 cell line overexpressing Her2 receptors. The proposed approach for designing ratiometric, antibody-guided TDD systems, where a "drug-switchable dye" conjugate and a reference dye are independently linked to an antibody, can be expanded to other drugs, dyes, and antibodies. Replacement of the green-emitting dye Flu, which was found not detectable in vivo, with a longer-wavelength (red or near-IR) switchable fluorophore should enable quantification of drug release in the body.
Collapse
Affiliation(s)
- Dvir Poplinger
- Department of Chemical Sciences, the Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel
| | - Maksym Bokan
- Department of Chemical Sciences, the Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel
| | - Arkadi Hesin
- Department of Molecular Biology, the Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel
| | - Ebaston Thankarajan
- Department of Chemical Sciences, the Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel
| | - Helena Tuchinsky
- Department of Molecular Biology, the Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel
| | - Gary Gellerman
- Department of Chemical Sciences, the Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel
| | - Leonid Patsenker
- Department of Chemical Sciences, the Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel
| |
Collapse
|
9
|
Lee I, Probst D, Klonoff D, Sode K. Continuous glucose monitoring systems - Current status and future perspectives of the flagship technologies in biosensor research -. Biosens Bioelectron 2021; 181:113054. [DOI: 10.1016/j.bios.2021.113054] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2020] [Revised: 01/23/2021] [Accepted: 01/27/2021] [Indexed: 12/14/2022]
|
10
|
Jones L, Hui A, Phan CM, Read ML, Azar D, Buch J, Ciolino JB, Naroo SA, Pall B, Romond K, Sankaridurg P, Schnider CM, Terry L, Willcox M. CLEAR - Contact lens technologies of the future. Cont Lens Anterior Eye 2021; 44:398-430. [PMID: 33775384 DOI: 10.1016/j.clae.2021.02.007] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Accepted: 02/01/2021] [Indexed: 12/20/2022]
Abstract
Contact lenses in the future will likely have functions other than correction of refractive error. Lenses designed to control the development of myopia are already commercially available. Contact lenses as drug delivery devices and powered through advancements in nanotechnology will open up further opportunities for unique uses of contact lenses. This review examines the use, or potential use, of contact lenses aside from their role to correct refractive error. Contact lenses can be used to detect systemic and ocular surface diseases, treat and manage various ocular conditions and as devices that can correct presbyopia, control the development of myopia or be used for augmented vision. There is also discussion of new developments in contact lens packaging and storage cases. The use of contact lenses as devices to detect systemic disease has mostly focussed on detecting changes to glucose levels in tears for monitoring diabetic control. Glucose can be detected using changes in colour, fluorescence or generation of electric signals by embedded sensors such as boronic acid, concanavalin A or glucose oxidase. Contact lenses that have gained regulatory approval can measure changes in intraocular pressure to monitor glaucoma by measuring small changes in corneal shape. Challenges include integrating sensors into contact lenses and detecting the signals generated. Various techniques are used to optimise uptake and release of the drugs to the ocular surface to treat diseases such as dry eye, glaucoma, infection and allergy. Contact lenses that either mechanically or electronically change their shape are being investigated for the management of presbyopia. Contact lenses that slow the development of myopia are based upon incorporating concentric rings of plus power, peripheral optical zone(s) with add power or non-monotonic variations in power. Various forms of these lenses have shown a reduction in myopia in clinical trials and are available in various markets.
Collapse
Affiliation(s)
- Lyndon Jones
- Centre for Ocular Research & Education (CORE), School of Optometry & Vision Science, University of Waterloo, Waterloo, Canada; Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong.
| | - Alex Hui
- School of Optometry and Vision Science, UNSW Sydney, Sydney, NSW, Australia
| | - Chau-Minh Phan
- Centre for Ocular Research & Education (CORE), School of Optometry & Vision Science, University of Waterloo, Waterloo, Canada; Centre for Eye and Vision Research (CEVR), 17W Hong Kong Science Park, Hong Kong
| | - Michael L Read
- Eurolens Research, Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
| | - Dimitri Azar
- Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, IL, USA; Verily Life Sciences, San Francisco, CA, USA
| | - John Buch
- Johnson & Johnson Vision Care, Jacksonville, FL, USA
| | - Joseph B Ciolino
- Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA
| | - Shehzad A Naroo
- College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK
| | - Brian Pall
- Johnson & Johnson Vision Care, Jacksonville, FL, USA
| | - Kathleen Romond
- Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, IL, USA
| | - Padmaja Sankaridurg
- School of Optometry and Vision Science, UNSW Sydney, Sydney, NSW, Australia; Brien Holden Vision Institute, Sydney, Australia
| | | | - Louise Terry
- School of Optometry and Vision Sciences, Cardiff University, UK
| | - Mark Willcox
- School of Optometry and Vision Science, UNSW Sydney, Sydney, NSW, Australia
| |
Collapse
|
11
|
Dual-dye systems comprising activatable fluorescein dye and hydrophobic or hydrophilic Cy5 reference fluorophore for ratiometric drug delivery monitoring. J Photochem Photobiol A Chem 2021. [DOI: 10.1016/j.jphotochem.2020.113113] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
12
|
Lee GH, Moon H, Kim H, Lee GH, Kwon W, Yoo S, Myung D, Yun SH, Bao Z, Hahn SK. Multifunctional materials for implantable and wearable photonic healthcare devices. NATURE REVIEWS. MATERIALS 2020; 5:149-165. [PMID: 32728478 PMCID: PMC7388681 DOI: 10.1038/s41578-019-0167-3] [Citation(s) in RCA: 205] [Impact Index Per Article: 51.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 11/28/2019] [Indexed: 05/20/2023]
Abstract
Numerous light-based diagnostic and therapeutic devices are routinely used in the clinic. These devices have a familiar look as items plugged in the wall or placed at patients' bedsides, but recently, many new ideas have been proposed for the realization of implantable or wearable functional devices. Many advances are being fuelled by the development of multifunctional materials for photonic healthcare devices. However, the finite depth of light penetration in the body is still a serious constraint for their clinical applications. In this Review, we discuss the basic concepts and some examples of state-of-the-art implantable and wearable photonic healthcare devices for diagnostic and therapeutic applications. First, we describe emerging multifunctional materials critical to the advent of next-generation implantable and wearable photonic healthcare devices and discuss the path for their clinical translation. Then, we examine implantable photonic healthcare devices in terms of their properties and diagnostic and therapeutic functions. We next describe exemplary cases of noninvasive, wearable photonic healthcare devices across different anatomical applications. Finally, we discuss the future research directions for the field, in particular regarding mobile healthcare and personalized medicine.
Collapse
Affiliation(s)
- Geon-Hui Lee
- Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), Pohang, South Korea
- Department of Chemical Engineering, Stanford University, Stanford, CA, USA
- These authors contributed equally: Geon-Hui Lee, Hanul Moon, Hyemin Kim
| | - Hanul Moon
- Department of Chemical Engineering, Stanford University, Stanford, CA, USA
- School of Electrical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea
- These authors contributed equally: Geon-Hui Lee, Hanul Moon, Hyemin Kim
| | - Hyemin Kim
- PHI Biomed Co., Seoul, South Korea
- These authors contributed equally: Geon-Hui Lee, Hanul Moon, Hyemin Kim
| | - Gae Hwang Lee
- Department of Chemical Engineering, Stanford University, Stanford, CA, USA
- Samsung Advanced Institute of Technology (SAIT), Samsung Electronics, Suwon, South Korea
| | - Woosung Kwon
- Department of Chemical and Biological Engineering, Sookmyung Women’s University, Seoul, South Korea
| | - Seunghyup Yoo
- School of Electrical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea
| | - David Myung
- Department of Chemical Engineering, Stanford University, Stanford, CA, USA
- Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA
| | - Seok Hyun Yun
- Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | - Zhenan Bao
- Department of Chemical Engineering, Stanford University, Stanford, CA, USA
| | - Sei Kwang Hahn
- Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), Pohang, South Korea
- Department of Chemical Engineering, Stanford University, Stanford, CA, USA
- PHI Biomed Co., Seoul, South Korea
| |
Collapse
|
13
|
Affiliation(s)
- Leonid Patsenker
- Department of Natural SciencesAriel University Ariel 40700 Israel
| | - Gary Gellerman
- Department of Natural SciencesAriel University Ariel 40700 Israel
| |
Collapse
|
14
|
Meng L, Turner APF, Mak WC. Soft and flexible material-based affinity sensors. Biotechnol Adv 2019; 39:107398. [PMID: 31071431 DOI: 10.1016/j.biotechadv.2019.05.004] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2018] [Revised: 05/01/2019] [Accepted: 05/04/2019] [Indexed: 01/11/2023]
Abstract
Recent advances in biosensors and point-of-care (PoC) devices are poised to change and expand the delivery of diagnostics from conventional lateral-flow assays and test strips that dominate the market currently, to newly emerging wearable and implantable devices that can provide continuous monitoring. Soft and flexible materials are playing a key role in propelling these trends towards real-time and remote health monitoring. Affinity biosensors have the capability to provide for diagnosis and monitoring of cancerous, cardiovascular, infectious and genetic diseases by the detection of biomarkers using affinity interactions. This review tracks the evolution of affinity sensors from conventional lateral-flow test strips to wearable/implantable devices enabled by soft and flexible materials. Initially, we highlight conventional affinity sensors exploiting membrane and paper materials which have been so successfully applied in point-of-care tests, such as lateral-flow immunoassay strips and emerging microfluidic paper-based devices. We then turn our attention to the multifarious polymer designs that provide both the base materials for sensor designs, such as PDMS, and more advanced functionalised materials that are capable of both recognition and transduction, such as conducting and molecularly imprinted polymers. The subsequent content discusses wearable soft and flexible material-based affinity sensors, classified as flexible and skin-mountable, textile materials-based and contact lens-based affinity sensors. In the final sections, we explore the possibilities for implantable/injectable soft and flexible material-based affinity sensors, including hydrogels, microencapsulated sensors and optical fibers. This area is truly a work in progress and we trust that this review will help pull together the many technological streams that are contributing to the field.
Collapse
Affiliation(s)
- Lingyin Meng
- Biosensors and Bioelectronics Centre, Department of Physics, Chemistry and Biology, Linköping University, SE-581 83 Linköping, Sweden
| | | | - Wing Cheung Mak
- Biosensors and Bioelectronics Centre, Department of Physics, Chemistry and Biology, Linköping University, SE-581 83 Linköping, Sweden.
| |
Collapse
|
15
|
Rozovsky A, Ebaston TM, Zaporozhets A, Bazylevich A, Tuchinsky H, Patsenker L, Gellerman G. Theranostic system for ratiometric fluorescence monitoring of peptide-guided targeted drug delivery. RSC Adv 2019; 9:32656-32664. [PMID: 35529716 PMCID: PMC9073098 DOI: 10.1039/c9ra06334j] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Accepted: 10/04/2019] [Indexed: 11/21/2022] Open
Abstract
Novel theranostic system that first combines a cancer-targeting peptide with a long-wavelength dual fluorescent dye IRD in order to provide ratiometric monitoring of anticancer drug delivery is developed and evaluated in pancreatic cancer cell line.
Collapse
Affiliation(s)
- Alex Rozovsky
- Department of Chemical Sciences
- Ariel University
- Ariel 40700
- Israel
| | - T. M. Ebaston
- Department of Chemical Sciences
- Ariel University
- Ariel 40700
- Israel
| | | | | | - Helena Tuchinsky
- Department of Molecular Biology
- Ariel University
- Ariel 40700
- Israel
| | - Leonid Patsenker
- Department of Chemical Sciences
- Ariel University
- Ariel 40700
- Israel
| | - Gary Gellerman
- Department of Chemical Sciences
- Ariel University
- Ariel 40700
- Israel
| |
Collapse
|
16
|
Lin YR, Hung CC, Chiu HY, Chang BH, Li BR, Cheng SJ, Yang JW, Lin SF, Chen GY. Noninvasive Glucose Monitoring with a Contact Lens and Smartphone. SENSORS (BASEL, SWITZERLAND) 2018; 18:E3208. [PMID: 30249021 PMCID: PMC6210255 DOI: 10.3390/s18103208] [Citation(s) in RCA: 44] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/15/2018] [Revised: 08/16/2018] [Accepted: 09/19/2018] [Indexed: 02/04/2023]
Abstract
Diabetes has become a chronic metabolic disorder, and the growing diabetes population makes medical care more important. We investigated using a portable and noninvasive contact lens as an ideal sensor for diabetes patients whose tear fluid contains glucose. The key feature is the reversible covalent interaction between boronic acid and glucose, which can provide a noninvasive glucose sensor for diabetes patients. We present a phenylboronic acid (PBA)-based HEMA contact lens that exhibits a reversible swelling/shrinking effect to change its thickness. The difference in thickness can be detected in a picture taken with a smartphone and analyzed using software. Our novel technique offers the following capabilities: (i) non-enzymatic and continuous glucose detection with the contact lens; (ii) no need for an embedded circuit and power source for the glucose sensor; and (iii) the use of a smartphone to detect the change in thickness of the contact lens with no need for additional photo-sensors. This technique is promising for a noninvasive measurement of the glucose level and simple implementation of glucose sensing with a smartphone.
Collapse
Affiliation(s)
- You-Rong Lin
- Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 300, Taiwan.
- Department of Electrical and Computer Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 30010, Taiwan.
| | - Chin-Chi Hung
- Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 300, Taiwan.
| | - Hsien-Yi Chiu
- Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu 30059, Taiwan.
- Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei 10051, Taiwan.
- Department of Dermatology, National Taiwan University Hospital, Taipei 10002, Taiwan.
- Department of Dermatology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.
| | - Bo-Han Chang
- Department of Applied Chemistry, National Chiao Tung University, Hsinchu 30010, Taiwan.
| | - Bor-Ran Li
- Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 300, Taiwan.
- Department of Applied Chemistry, National Chiao Tung University, Hsinchu 30010, Taiwan.
| | - Sheng-Jen Cheng
- Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 300, Taiwan.
- Department of Electrical and Computer Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 30010, Taiwan.
| | - Jia-Wei Yang
- Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 300, Taiwan.
- Department of Electrical and Computer Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 30010, Taiwan.
| | - Shien-Fong Lin
- Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 300, Taiwan.
- Department of Electrical and Computer Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 30010, Taiwan.
| | - Guan-Yu Chen
- Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Chiao Tung University, Hsinchu 300, Taiwan.
- Department of Biological Science and Technology, National Chiao Tung University, Hsinchu 30010, Taiwan.
| |
Collapse
|
17
|
Tseng RC, Chen CC, Hsu SM, Chuang HS. Contact-Lens Biosensors. SENSORS (BASEL, SWITZERLAND) 2018; 18:E2651. [PMID: 30104496 PMCID: PMC6111605 DOI: 10.3390/s18082651] [Citation(s) in RCA: 62] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Revised: 08/06/2018] [Accepted: 08/10/2018] [Indexed: 12/14/2022]
Abstract
Rapid diagnosis and screening of diseases have become increasingly important in predictive and preventive medicine as they improve patient treatment strategies and reduce cost as well as burden on our healthcare system. In this regard, wearable devices are emerging as effective and reliable point-of-care diagnostics that can allow users to monitor their health at home. These wrist-worn, head-mounted, smart-textile, or smart-patches devices can offer valuable information on the conditions of patients as a non-invasive form of monitoring. However, they are significantly limited in monitoring physiological signals and biomechanics, and, mostly, rely on the physical attributes. Recently, developed wearable devices utilize body fluids, such as sweat, saliva, or skin interstitial fluid, and electrochemical interactions to allow continuous physiological condition and disease monitoring for users. Among them, tear fluid has been widely utilized in the investigation of ocular diseases, diabetes, and even cancers, because of its easy accessibility, lower complexity, and minimal invasiveness. By determining the concentration change of analytes within the tear fluid, it would be possible to identify disease progression and allow patient-oriented therapies. Considering the emerging trend of tear-based biosensing technology, this review article aims to focus on an overview of the tear fluid as a detection medium for certain diseases, such as ocular disorders, diabetes, and cancer. In addition, the rise and application of minimally invasive detection and monitoring via integrated contact lens biosensors will also be addressed, in regards to their practicality and current developmental progress.
Collapse
Affiliation(s)
- Ryan Chang Tseng
- Department of Biomedical Engineering, National Cheng Kung University, Tainan City 701, Taiwan.
| | - Ching-Chuen Chen
- Department of Biomedical Engineering, National Cheng Kung University, Tainan City 701, Taiwan.
| | - Sheng-Min Hsu
- Department of Ophthalmology, National Cheng Kung University Hospital, Tainan City 704, Taiwan.
| | - Han-Sheng Chuang
- Department of Biomedical Engineering, National Cheng Kung University, Tainan City 701, Taiwan.
- Medical Device Innovation Center, National Cheng Kung University, Tainan City 701, Taiwan.
| |
Collapse
|
18
|
Lin CE, Ito Y, Deng A, Johns J, Matloff D, Cook CB, Sode K, La Belle JT. A Disposable Tear Glucose Biosensor-Part 5: Improvements in Reagents and Tear Sampling Component. J Diabetes Sci Technol 2018; 12:842-846. [PMID: 29667855 PMCID: PMC6134317 DOI: 10.1177/1932296818769944] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
A tear glucose (TG) sensor with an integrated tear sampler can provide a noninvasive method for calibrating the continuous TG contact lens and monitoring glucose. Expanding from previous work, an improved TG sensor that implements dried reagents, genetically modified glucose dehydrogenase (GDH), and a tear sampler was developed and compared against the TG sensor prepared with commercial GDH. It was found that neither sensor was affected by the tear interferents: ascorbic acid, acetaminophen, and uric acid. The sensor prepared with commercial GDH generated higher current. This suggests that using enzymes with lower Km may be advantageous when operating in low glucose environments like tears. The improved TG sensor also demonstrated the potential of integrating Schirmer's test strip as a tear sampler for self-monitoring of TG.
Collapse
Affiliation(s)
- Chi En Lin
- School of Biological and Health Systems
Engineering, Arizona State University, Tempe, AZ, USA
| | - Yuka Ito
- Department of Biotechnology and Life
Science, Graduate School of Engineering, Tokyo University of Agriculture and
Technology, Koganei, Tokyo, Japan
| | - Anna Deng
- School of Biological and Health Systems
Engineering, Arizona State University, Tempe, AZ, USA
| | - Jared Johns
- School of Biological and Health Systems
Engineering, Arizona State University, Tempe, AZ, USA
| | - Daniel Matloff
- School of Biological and Health Systems
Engineering, Arizona State University, Tempe, AZ, USA
| | - Curtiss B. Cook
- School of Medicine, Mayo Clinic Arizona,
Scottsdale, AZ, USA
| | - Koji Sode
- Department of Biotechnology and Life
Science, Graduate School of Engineering, Tokyo University of Agriculture and
Technology, Koganei, Tokyo, Japan
- Joint Department of Biomedical
Engineering, University of North Carolina at Chapel Hill, North Carolina State
University, Chapel Hill, NC, USA
| | - Jeffrey T. La Belle
- School of Biological and Health Systems
Engineering, Arizona State University, Tempe, AZ, USA
- School of Medicine, Mayo Clinic Arizona,
Scottsdale, AZ, USA
- Jeffrey T. La Belle, PhD, Arizona State
University, 550 E Orange St, Tempe, AZ 85287, USA.
| |
Collapse
|
19
|
Yáñez E, Cywiak M, Juan Manuel Franco S. Gaussian probe beam with high spherical aberration for glucose concentration measurement. APPLIED OPTICS 2018; 57:4153-4157. [PMID: 29791389 DOI: 10.1364/ao.57.004153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/29/2018] [Accepted: 04/16/2018] [Indexed: 06/08/2023]
Abstract
We demonstrate that an optical probe beam with high spherical aberration used for glucose concentration measurements gives better sensitivity compared to a probe beam free of aberrations, under similar conditions. We place a singlet focusing lens at a large distance from a laser source with a Gaussian intensity profile to obtain a spherically aberrated probe beam with negligible truncation. The aberrated probe beam propagates through a transparent liquid sample. Intensity profiles of the transmitted beam are recorded by means of a homodyne profiler to perform the glucose concentration measurements accurately.
Collapse
|
20
|
Park S, Lee DY. Materials and Applications of Smart Diagnostic Contact Lens Systems. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2018; 1078:155-160. [PMID: 30357623 DOI: 10.1007/978-981-13-0950-2_9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Contact lenses were originally developed for the purpose of vision correction, but they have recently been used for various purposes. Because contact lenses are minimally invasive, they are used in diagnostic and drug delivery applications. In particular, interest in using contact lenses for the purpose of diagnosing diseases by fusing contact lenses with information technology (IT), nanotechnology (NT), and biotechnology (BT) is increasing. These contact lens-based platforms are getting more attention as Google and Novartis develop contact lenses for diabetes diagnosis. Therefore, this chapter introduces materials that can be used for contact lens materials and diagnostic contact lenses, and discusses future prospects.
Collapse
Affiliation(s)
- Sijin Park
- Department of Bioengineering, College of Engineering, and BK21 PLUS Future Biopharmaceutical Human Resources Training and Research Team, Hanyang University, Seoul, South Korea
| | - Dong Yun Lee
- Department of Bioengineering, College of Engineering, and BK21 PLUS Future Biopharmaceutical Human Resources Training and Research Team, Hanyang University, Seoul, South Korea.
| |
Collapse
|
21
|
Elshaarani T, Yu H, Wang L, Zain-ul-Abdin ZUA, Ullah RS, Haroon M, Khan RU, Fahad S, Khan A, Nazir A, Usman M, Naveed KUR. Synthesis of hydrogel-bearing phenylboronic acid moieties and their applications in glucose sensing and insulin delivery. J Mater Chem B 2018; 6:3831-3854. [DOI: 10.1039/c7tb03332j] [Citation(s) in RCA: 42] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
In past few years, phenylboronic acids (PBAs) have attracted researcher's attention due to their unique responsiveness towards diol-containing molecules such as glucose.
Collapse
|
22
|
Bruen D, Delaney C, Florea L, Diamond D. Glucose Sensing for Diabetes Monitoring: Recent Developments. SENSORS (BASEL, SWITZERLAND) 2017; 17:E1866. [PMID: 28805693 PMCID: PMC5579887 DOI: 10.3390/s17081866] [Citation(s) in RCA: 317] [Impact Index Per Article: 45.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/13/2017] [Revised: 08/03/2017] [Accepted: 08/04/2017] [Indexed: 02/07/2023]
Abstract
This review highlights recent advances towards non-invasive and continuous glucose monitoring devices, with a particular focus placed on monitoring glucose concentrations in alternative physiological fluids to blood.
Collapse
Affiliation(s)
- Danielle Bruen
- Insight Centre for Data Analytics, National Centre for Sensor Research, School of Chemical Sciences, Dublin City University, Dublin 9, Ireland.
| | - Colm Delaney
- Insight Centre for Data Analytics, National Centre for Sensor Research, School of Chemical Sciences, Dublin City University, Dublin 9, Ireland.
| | - Larisa Florea
- Insight Centre for Data Analytics, National Centre for Sensor Research, School of Chemical Sciences, Dublin City University, Dublin 9, Ireland.
| | - Dermot Diamond
- Insight Centre for Data Analytics, National Centre for Sensor Research, School of Chemical Sciences, Dublin City University, Dublin 9, Ireland.
| |
Collapse
|
23
|
An BW, Shin JH, Kim SY, Kim J, Ji S, Park J, Lee Y, Jang J, Park YG, Cho E, Jo S, Park JU. Smart Sensor Systems for Wearable Electronic Devices. Polymers (Basel) 2017; 9:E303. [PMID: 30970981 PMCID: PMC6418677 DOI: 10.3390/polym9080303] [Citation(s) in RCA: 69] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Revised: 07/20/2017] [Accepted: 07/22/2017] [Indexed: 01/04/2023] Open
Abstract
Wearable human interaction devices are technologies with various applications for improving human comfort, convenience and security and for monitoring health conditions. Healthcare monitoring includes caring for the welfare of every person, which includes early diagnosis of diseases, real-time monitoring of the effects of treatment, therapy, and the general monitoring of the conditions of people's health. As a result, wearable electronic devices are receiving greater attention because of their facile interaction with the human body, such as monitoring heart rate, wrist pulse, motion, blood pressure, intraocular pressure, and other health-related conditions. In this paper, various smart sensors and wireless systems are reviewed, the current state of research related to such systems is reported, and their detection mechanisms are compared. Our focus was limited to wearable and attachable sensors. Section 1 presents the various smart sensors. In Section 2, we describe multiplexed sensors that can monitor several physiological signals simultaneously. Section 3 provides a discussion about short-range wireless systems including bluetooth, near field communication (NFC), and resonance antenna systems for wearable electronic devices.
Collapse
Affiliation(s)
- Byeong Wan An
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Jung Hwal Shin
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - So-Yun Kim
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Joohee Kim
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Sangyoon Ji
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Jihun Park
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Youngjin Lee
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Jiuk Jang
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Young-Geun Park
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Eunjin Cho
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Subin Jo
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| | - Jang-Ung Park
- School of Materials Science and Engineering, Wearable Electronics Research Group, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
| |
Collapse
|
24
|
Inoue Y, Inoue M, Saito M, Yoshikawa H, Tamiya E. Sensitive Detection of Glycated Albumin in Human Serum Albumin Using Electrochemiluminescence. Anal Chem 2017; 89:5909-5915. [DOI: 10.1021/acs.analchem.7b00280] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Yuki Inoue
- Department
of Applied Physics, Graduate School of Engineering, Osaka University, 2-1,
Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Mikako Inoue
- Department
of Pharmacology and Toxicology, Faculty of Arts and Sciences, University of Toronto, 27 King’s College Circle, Toronto, Ontario M5S 1A1, Canada
| | - Masato Saito
- Department
of Applied Physics, Graduate School of Engineering, Osaka University, 2-1,
Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Hiroyuki Yoshikawa
- Department
of Applied Physics, Graduate School of Engineering, Osaka University, 2-1,
Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Eiichi Tamiya
- Department
of Applied Physics, Graduate School of Engineering, Osaka University, 2-1,
Yamadaoka, Suita, Osaka 565-0871, Japan
| |
Collapse
|
25
|
Gabriel EFM, Garcia PT, Lopes FM, Coltro WKT. Paper-Based Colorimetric Biosensor for Tear Glucose Measurements. MICROMACHINES 2017. [PMCID: PMC6189872 DOI: 10.3390/mi8040104] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
This paper describes a paper-based colorimetric biosensor for measuring glucose concentration levels in human tear samples. Colorimetric biosensors were wax printed on paper platforms and modified with chitosan previously prepared in acetic acid. The proposed device was explored to measure the glucose levels in human tear samples using 3,3′,5,5′-tetramethylbenzydine (TMB) as the chromogenic reagent. The paper-based colorimetric biosensor exhibited a linear behavior for the glucose concentration range between 0.1 and 1.0 mM. The achieved analytical sensitivity and limit of detection (LOD) were 84 AU/mM and 50 µM, respectively. Moreover, the device provided analytical reliability and no statistical difference when compared to the data recorded with a commercial glucometer. The proof-of-concept of our device was successfully demonstrated by measuring the glucose levels in six tear samples from nondiabetic subjects. In general, the results showed that the colorimetric biosensor has noticeable potential to be used as a powerful tool for tear glucose monitoring, since this fluid offers lower potential interferences, non-invasive sample collection and is pain-free. Furthermore, the proposed device could facilitate the treatment of diabetic patients who need constant control of glucose levels and cannot tolerate multiple finger sticks per day.
Collapse
Affiliation(s)
| | - Paulo Tarso Garcia
- Instituto de Química, Universidade Federal de Goiás, 74690-900 Goiânia, GO, Brazil; (E.F.M.G.); (P.T.G.)
| | - Flavio Marques Lopes
- Faculdade de Farmácia, Universidade Federal de Goiás, 74605-170 Goiânia, GO, Brazil;
| | - Wendell Karlos Tomazelli Coltro
- Instituto de Química, Universidade Federal de Goiás, 74690-900 Goiânia, GO, Brazil; (E.F.M.G.); (P.T.G.)
- Instituto Nacional de Ciência e Tecnologia em Bioanalítica (INCTBio), 13083-970 Campinas, SP, Brazil
- Correspondence: ; Tel.: +55-62-3521-1127
| |
Collapse
|
26
|
Ruan JL, Chen C, Shen JH, Zhao XL, Qian SH, Zhu ZG. A Gelated Colloidal Crystal Attached Lens for Noninvasive Continuous Monitoring of Tear Glucose. Polymers (Basel) 2017; 9:polym9040125. [PMID: 30970805 PMCID: PMC6432312 DOI: 10.3390/polym9040125] [Citation(s) in RCA: 51] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2017] [Revised: 03/15/2017] [Accepted: 03/23/2017] [Indexed: 01/20/2023] Open
Abstract
Patients of diabetes mellitus urgently need noninvasive and continuous glucose monitoring in daily point-of-care. As the tear glucose concentration has a positive correlation with that in blood, the hydrogel colloidal crystal integrated into contact lens possesses promising potential for noninvasive monitoring of glucose in tears. This paper presents a new glucose-responsive sensor, which consists a crystalline colloidal array (CCA) embedded in hydrogel matrix, attached onto a rigid gas permeable (RGP) contact lens. This novel sensing lens is able to selectively diffract visible light, whose wavelength shifts between 567 and 468 nm according to the alternation of the glucose concentration between 0 and 50 mM and its visible color change between reddish yellow, green, and blue. The detection limit of responsive glucose concentration can be reduced to 0.05 mM. Its combination with a contact lens endows it with excellent biocompatibility and portability, which shows great possibility for it to push the development of glucose-detecting devices into new era.
Collapse
Affiliation(s)
- Jia-Li Ruan
- Department of Ophthalmology, EENT Hospital of Fudan University, Shanghai 200031, China.
| | - Cheng Chen
- School of Environmental and Materials Engineering, College of Engineering, Shanghai Polytechnic University, Shanghai 201209, China.
| | - Jian-Hua Shen
- Key Laboratory for Ultrafine Materials of Ministry of Education, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.
| | - Xue-Ling Zhao
- School of Environmental and Materials Engineering, College of Engineering, Shanghai Polytechnic University, Shanghai 201209, China.
| | - Shao-Hong Qian
- Department of Ophthalmology, EENT Hospital of Fudan University, Shanghai 200031, China.
| | - Zhi-Gang Zhu
- School of Environmental and Materials Engineering, College of Engineering, Shanghai Polytechnic University, Shanghai 201209, China.
| |
Collapse
|
27
|
Tiangco C, Andar A, Quarterman J, Ge X, Sevilla F, Rao G, Stinchcomb A, Bunge A, Tolosa L. Measuring transdermal glucose levels in neonates by passive diffusion: an in vitro porcine skin model. Anal Bioanal Chem 2017; 409:3475-3482. [PMID: 28283718 DOI: 10.1007/s00216-017-0289-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2016] [Revised: 02/01/2017] [Accepted: 02/28/2017] [Indexed: 11/30/2022]
Abstract
Current glucose monitoring techniques for neonates rely heavily on blood glucose monitors which require intermittent blood collection through skin-penetrating pricks on the heel or fingers. This procedure is painful and often not clinically conducive, which presents a need for a noninvasive method for monitoring glucose in neonates. Our motivation for this study was to develop an in vitro method for measuring passive diffusion of glucose in premature neonatal skin using a porcine skin model. Such a model will allow us to initially test new devices for noninvasive glucose monitoring without having to do in vivo testing of newborns. The in vitro model is demonstrated by comparing uncompromised and tape-stripped skin in an in-line flow-through diffusion apparatus with glucose concentrations that mimic the hypo-, normo-, and hyper-glycemic conditions in the neonate (2.0, 5.0, and 20 mM, respectively). Transepidermal water loss (TEWL) of the tape-stripped skin was approximately 20 g m-2 h-1, which closely mimics TEWL for neonatal skin at about 190 days post-conceptional age. The tape-stripped skin showed a >15-fold increase in glucose diffusion compared to the uncompromised skin. The very small concentrations of collected glucose were measured with a highly selective and highly sensitive fluorescent glucose biosensor based on the glucose binding protein (GBP). The demonstrated method of glucose determination is noninvasive and painless, which makes it especially desirable for glucose testing in neonates and children. This study is an important step towards an in vitro model for noninvasive real-time glucose monitoring that may be easily transferred to the clinic for glucose monitoring in neonates. Graphical Abstract Glucose diffusion through model skin was measured using an in-line flow-through diffusion apparatus with glucose solutions mimicking hypo-, normo- and hyperglycemia in the neonate. Phosphate buffered saline was added to the top chamber and the glucose that diffused through the model skin into the buffer was measured using a fluorescent glucose binding protein biosensor.
Collapse
Affiliation(s)
- Cristina Tiangco
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA.,The Graduate School, University of Santo Tomas, España Boulevard, 1015, Manila, Philippines
| | - Abhay Andar
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA.,Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, Baltimore, MD, 21201, USA
| | - Juliana Quarterman
- Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, Baltimore, MD, 21201, USA
| | - Xudong Ge
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA
| | - Fortunato Sevilla
- The Graduate School, University of Santo Tomas, España Boulevard, 1015, Manila, Philippines
| | - Govind Rao
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA
| | - Audra Stinchcomb
- Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, Baltimore, MD, 21201, USA
| | - Annette Bunge
- Chemical and Biological Engineering Department, Colorado School of Mines, 1500 Illinois Street, Golden, CO, 80401, USA
| | - Leah Tolosa
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA.
| |
Collapse
|
28
|
Trivedi DK, Hollywood KA, Goodacre R. Metabolomics for the masses: The future of metabolomics in a personalized world. NEW HORIZONS IN TRANSLATIONAL MEDICINE 2017; 3:294-305. [PMID: 29094062 PMCID: PMC5653644 DOI: 10.1016/j.nhtm.2017.06.001] [Citation(s) in RCA: 79] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Revised: 06/02/2017] [Accepted: 06/02/2017] [Indexed: 02/07/2023]
Abstract
Current clinical practices focus on a small number of biochemical directly related to the pathophysiology with patients and thus only describe a very limited metabolome of a patient and fail to consider the interations of these small molecules. This lack of extended information may prevent clinicians from making the best possible therapeutic interventions in sufficient time to improve patient care. Various post-genomics '('omic)' approaches have been used for therapeutic interventions previously. Metabolomics now a well-established'omics approach, has been widely adopted as a novel approach for biomarker discovery and in tandem with genomics (especially SNPs and GWAS) has the potential for providing systemic understanding of the underlying causes of pathology. In this review, we discuss the relevance of metabolomics approaches in clinical sciences and its potential for biomarker discovery which may help guide clinical interventions. Although a powerful and potentially high throughput approach for biomarker discovery at the molecular level, true translation of metabolomics into clinics is an extremely slow process. Quicker adaptation of biomarkers discovered using metabolomics can be possible with novel portable and wearable technologies aided by clever data mining, as well as deep learning and artificial intelligence; we shall also discuss this with an eye to the future of precision medicine where metabolomics can be delivered to the masses.
Collapse
Affiliation(s)
| | | | - Royston Goodacre
- Manchester Institute of Biotechnology and School of Chemistry, University of Manchester, 131 Princess Street, Manchester M1 7DN, UK
| |
Collapse
|
29
|
Bettazzi F, Marrazza G, Minunni M, Palchetti I, Scarano S. Biosensors and Related Bioanalytical Tools. PAST, PRESENT AND FUTURE CHALLENGES OF BIOSENSORS AND BIOANALYTICAL TOOLS IN ANALYTICAL CHEMISTRY: A TRIBUTE TO PROFESSOR MARCO MASCINI 2017. [DOI: 10.1016/bs.coac.2017.05.003] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
|
30
|
Abstract
: The tear film is a complex multilayer film consisting of various proteins, enzymes, and lipids and can express a number of biomarkers in cases of disease. The development of a contact lens sensor presents a noninvasive alternative for the detection and management of various diseases. Recent work has resulted in the commercialization of a device to monitor intraocular pressure for up to 24 h, and there are extensive efforts underway to develop a contact lens sensor capable of continuous glucose tear film monitoring to manage diabetes. This clinical perspective will highlight the major developments within this field and list some of the major challenges that still need to be addressed.
Collapse
|
31
|
Gabriel EFM, Garcia PT, Cardoso TMG, Lopes FM, Martins FT, Coltro WKT. Highly sensitive colorimetric detection of glucose and uric acid in biological fluids using chitosan-modified paper microfluidic devices. Analyst 2016; 141:4749-56. [PMID: 27272206 DOI: 10.1039/c6an00430j] [Citation(s) in RCA: 115] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
This paper describes the modification of microfluidic paper-based analytical devices (μPADs) with chitosan to improve the analytical performance of colorimetric measurements associated with enzymatic bioassays. Chitosan is a natural biopolymer extensively used to modify biosensing surfaces due to its capability of providing a suitable microenvironment for the direct electron transfer between an enzyme and a reactive surface. This hypothesis was investigated using glucose and uric acid (UA) colorimetric assays as model systems. The best colorimetric sensitivity for glucose and UA was achieved using a chromogenic solution composed of 4-aminoantipyrine and sodium 3,5-dichloro-2-hydroxy-benzenesulfonate (4-AAP/DHBS), which provided a linear response for a concentration range between 0.1 and 1.0 mM. Glucose and UA were successfully determined in artificial serum samples with accuracies between 87 and 114%. The limits of detection (LODs) found for glucose and UA assays were 23 and 37 μM, respectively. The enhanced analytical performance of chitosan-modified μPADs allowed the colorimetric detection of glucose in tear samples from four nondiabetic patients. The achieved concentration levels ranged from 130 to 380 μM. The modified μPADs offered analytical reliability and accuracy as well as no statistical difference from the values achieved through a reference method. Based on the presented results, the proposed μPAD can be a powerful alternative tool for non-invasive glucose analysis.
Collapse
Affiliation(s)
- Ellen F M Gabriel
- Instituto de Química, Universidade Federal de Goiás, 74690-900, Goiânia, GO, Brazil.
| | | | | | | | | | | |
Collapse
|
32
|
Miller JD, Najafi B, Armstrong DG. Current Standards and Advances in Diabetic Ulcer Prevention and Elderly Fall Prevention Using Wearable Technology. CURRENT GERIATRICS REPORTS 2015. [DOI: 10.1007/s13670-015-0136-7] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
33
|
Wang HC, Lee AR. Recent developments in blood glucose sensors. J Food Drug Anal 2015; 23:191-200. [PMID: 28911373 PMCID: PMC9351764 DOI: 10.1016/j.jfda.2014.12.001] [Citation(s) in RCA: 137] [Impact Index Per Article: 15.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2014] [Revised: 11/25/2014] [Accepted: 12/24/2014] [Indexed: 02/08/2023] Open
Abstract
Diabetes has recently become a leading cause of death worldwide. To date, although there is no means to cure or prevent diabetes, appropriate medication and blood sugar monitoring can enhance treatment efficiency, alleviate the symptoms, and diminish the complications of the condition. This review article deals with current growth areas in the market for blood glucose sensors and possible future alternatives, which are generally considered to be the point sample test and the continuous glucose monitor (CGM). Most glucose sensors are enzyme-based, whereas others are enzyme-free. The former class is sensitive and some products are extensively employed for daily self-sensing and in hospital environments as reliable diagnostic tools. The latter class, particularly the boronic acid fluorescent sensor, is facile and extremely promising. Practicality demands that all types of sensors offer accuracy, specificity, and real-time detection.
Collapse
|
34
|
Cha KH, Jensen GC, Balijepalli AS, Cohan BE, Meyerhoff ME. Evaluation of Commercial Glucometer Test Strips for Potential Measurement of Glucose in Tears. Anal Chem 2014; 86:1902-8. [DOI: 10.1021/ac4040168] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Kyoung Ha Cha
- Department
of Chemistry, University of Michigan, Ann Arbor, Michigan, 48109-1055, United States
| | - Gary C. Jensen
- Department
of Chemistry, University of Michigan, Ann Arbor, Michigan, 48109-1055, United States
| | - Anant S. Balijepalli
- Department
of Chemistry, University of Michigan, Ann Arbor, Michigan, 48109-1055, United States
| | - Bruce E. Cohan
- EyeLab Group LLC, 2350 Washtenaw
Avenue No. 4, Ann Arbor, Michigan, 48104-4525, United States
| | - Mark E. Meyerhoff
- Department
of Chemistry, University of Michigan, Ann Arbor, Michigan, 48109-1055, United States
| |
Collapse
|
35
|
Harlow GP, Zakharov LN, Wu G, Liu SY. Thermodynamically Controlled, Dynamic Binding of Diols to a 1,2-BN Cyclohexane Derivative. Organometallics 2013; 32:6650-6653. [PMID: 25798022 DOI: 10.1021/om400697r] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The reversible covalent binding of diols to an N-Bn 1,2-BN cyclohexane has been studied by 11B and 1H NMR spectroscopy and single-crystal X-ray diffraction analysis. The activation barrier for the reversible B-N Lewis acid-base interaction has been measured by variable-temperature NMR with bound (2R,3R)-(-)-2,3-butanediol (Tc = -40 °C, ΔG‡ = 11.2 ± 0.2 kcal mol-1). Deuterium labeling experiments demonstrate that ligand exchange is reversible and rapid at room temperature, and competitive binding studies establish diol association as a thermodynamically controlled process.
Collapse
Affiliation(s)
- Gregory P Harlow
- Department of Chemistry and Biochemistry, University of Oregon, Eugene, Oregon 97403-1253, United States
| | - Lev N Zakharov
- Department of Chemistry and Biochemistry, University of Oregon, Eugene, Oregon 97403-1253, United States
| | - Gang Wu
- Department of Chemistry, Queen's University, Kingston, Ontario K7L 3N6, Canada
| | - Shih-Yuan Liu
- Department of Chemistry and Biochemistry, University of Oregon, Eugene, Oregon 97403-1253, United States
| |
Collapse
|
36
|
Falk M, Andoralov V, Silow M, Toscano MD, Shleev S. Miniature biofuel cell as a potential power source for glucose-sensing contact lenses. Anal Chem 2013; 85:6342-8. [PMID: 23735164 DOI: 10.1021/ac4006793] [Citation(s) in RCA: 92] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
A microscale membrane-less biofuel cell, capable of generating electrical energy from human lachrymal liquid, was developed by utilizing the ascorbate and oxygen naturally present in tears as fuel and oxidant. The biodevice is based on three-dimensional nanostructured gold electrodes covered with abiotic (conductive organic complex) and biological (redox enzyme) materials functioning as efficient anodic and cathodic catalysts, respectively. Three-dimensional nanostructured electrodes were fabricated by modifying 100 μm gold wires with 17 nm gold nanoparticles, which were further modified with tetrathiafulvalene-tetracyanoquinodimethane conducting complex to create the anode and with Myrothecium verrucaria bilirubin oxidase to create the biocathode. When operated in human tears, the biodevice exhibited the following characteristics: an open circuit voltage of 0.54 V, a maximal power density of 3.1 μW cm(-2) at 0.25 V and 0.72 μW cm(-2) at 0.4 V, with a stable current density output of over 0.55 μA cm(-2) at 0.4 V for 6 h of continuous operation. These findings support our proposition that an ascorbate/oxygen biofuel cell could be a suitable power source for glucose-sensing contact lenses to be used for continuous health monitoring by diabetes patients.
Collapse
Affiliation(s)
- Magnus Falk
- Biomedical Sciences, Health & Society, Malmö University, 205 06 Malmö, Sweden
| | | | | | | | | |
Collapse
|
37
|
Gifford R. Continuous glucose monitoring: 40 years, what we've learned and what's next. Chemphyschem 2013; 14:2032-44. [PMID: 23649735 DOI: 10.1002/cphc.201300172] [Citation(s) in RCA: 71] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2013] [Indexed: 01/05/2023]
Abstract
After 40 years of research and development, today continuous glucose monitoring (CGM) is demonstrating the benefit it provides for millions with diabetes. To provide in vivo accuracy, new permselective membranes and mediated systems have been developed to prevent enzyme saturation and to minimize interference signals. Early in vivo implanted sensor research clearly showed that the foreign body response was a more difficult issue to overcome. Understanding the biological interface and circumventing the inflammatory response continue to drive development of a CGM sensor with accuracy and reliability performance suitable in a closed-loop artificial pancreas. Along with biocompatible polymer development, other complimentary algorithm and data analysis techniques have improved the performance of commercial systems significantly. For example, the mean average relative difference of Dexcom's CGM system improved from 26 to 14% and its use-life was extended from 3 to 7 d. Significant gains in usability, including size, flexibility, insertion, calibration, and data interface, have been incorporated into new generations of commercial CGM systems. Besides Medtronic, Dexcom, and Abbott, other major players are also investing in CGM. Becton Dickinson is conducting clinical trials with an optical galactose glucose binding system. Development of fully implanted sensor systems fulfills the desire for a discreet, reliable CGM system. Research continues to find innovative ways to help make living with diabetes easier and more normal, and new segments are being pursued (intensive care unit, surgery, behavior modification) in which CGM is being utilized.
Collapse
Affiliation(s)
- Raeann Gifford
- Life Science, Acreo Swedish ICT AB, Box 787 SE-601 17 Norrköping, Sweden.
| |
Collapse
|
38
|
Nichols SP, Koh A, Storm WL, Shin JH, Schoenfisch MH. Biocompatible materials for continuous glucose monitoring devices. Chem Rev 2013; 113:2528-49. [PMID: 23387395 PMCID: PMC3624030 DOI: 10.1021/cr300387j] [Citation(s) in RCA: 188] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Scott P. Nichols
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
| | - Ahyeon Koh
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
| | - Wesley L. Storm
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
| | - Jae Ho Shin
- Department of Chemistry, Kwangwoon University, Seoul, Korea
| | - Mark H. Schoenfisch
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
| |
Collapse
|
39
|
Abstract
Biomaterials are being used for the healthcare applications from ancient times. But subsequent evolution has made them more versatile and has increased their utility. Biomaterials have revolutionized the areas like bioengineering and tissue engineering for the development of novel strategies to combat life threatening diseases. Together with biomaterials, stem cell technology is also being used to improve the existing healthcare facilities. These concepts and technologies are being used for the treatment of different diseases like cardiac failure, fractures, deep skin injuries, etc. Introduction of nanomaterials on the other hand is becoming a big hope for a better and an affordable healthcare. Technological advancements are underway for the development of continuous monitoring and regulating glucose levels by the implantation of sensor chips. Lab-on-a-chip technology is expected to modernize the diagnostics and make it more easy and regulated. Other area which can improve the tomorrow’s healthcare is drug delivery. Micro-needles have the potential to overcome the limitations of conventional needles and are being studied for the delivery of drugs at different location in human body. There is a huge advancement in the area of scaffold fabrication which has improved the potentiality of tissue engineering. Most emerging scaffolds for tissue engineering are hydrogels and cryogels. Dynamic hydrogels have huge application in tissue engineering and drug delivery. Furthermore, cryogels being supermacroporous allow the attachment and proliferation of most of the mammalian cell types and have shown application in tissue engineering and bioseparation. With further developments we expect these technologies to hit the market in near future which can immensely improve the healthcare facilities.
Collapse
Affiliation(s)
- Sumrita Bhat
- Department of Biological Science and Bioengineering; Indian Institute of Technology; Kanpur, India
| | - Ashok Kumar
- Department of Biological Science and Bioengineering; Indian Institute of Technology; Kanpur, India
| |
Collapse
|
40
|
Kirschner CM, Anseth KS. Hydrogels in Healthcare: From Static to Dynamic Material Microenvironments. ACTA MATERIALIA 2013; 61:931-944. [PMID: 23929381 PMCID: PMC3735227 DOI: 10.1016/j.actamat.2012.10.037] [Citation(s) in RCA: 150] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Advances in hydrogel design have revolutionized the way biomaterials are applied to address biomedical needs. Hydrogels were introduced in medicine over 50 years ago and have evolved from static, bioinert materials to dynamic, bioactive microenvironments, which can be used to direct specific biological responses such as cellular ingrowth in wound healing or on-demand delivery of therapeutics. Two general classes of mechanisms, those defined by the user and those dictated by the endogenous cells and tissues, can control dynamic hydrogel microenvironments. These highly tunable materials have provided bioengineers and biological scientists with new ways to not only treat patients in the clinic but to study the fundamental cellular responses to engineered microenvironments as well. Here, we provide a brief history of hydrogels in medicine and follow with a discussion of the synthesis and implementation of dynamic hydrogel microenvironments for healthcare-related applications.
Collapse
Affiliation(s)
- Chelsea M. Kirschner
- Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado, USA
| | - Kristi S. Anseth
- Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado, USA
- Biofrontiers Institute, University of Colorado, Boulder, Colorado, USA
- Howard Hughes Medical Institute, University of Colorado, Boulder, Colorado, USA
| |
Collapse
|
41
|
Asantewaa Y, Aylott J, Burley JC, Billa N, Roberts CJ. Correlating physicochemical properties of boronic Acid-chitosan conjugates to glucose adsorption sensitivity. Pharmaceutics 2012; 5:69-80. [PMID: 24300397 PMCID: PMC3834934 DOI: 10.3390/pharmaceutics5010069] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2012] [Revised: 12/10/2012] [Accepted: 12/18/2012] [Indexed: 11/18/2022] Open
Abstract
Phenyl boronic acid (PBA), which is known to interact with glucose, was covalently bonded to chitosan by direct reductive N-alkylation of chitosan with 4-formylphenylboronic acid (4-FPBA). Evidence of PBA bonding on chitosan was assessed by FTIR, ToF-SIMS, SEM, DSC and glucose adsorption sensitivity measurements. FTIR spectra showed strong signals at 1560 and 630 cm-1 indicating the formation of p-substituted benzene. Similarly, ToF-SIMS analyses on the conjugates registered fragments of boron ion (B-) at 11.0 m/z whose intensity increased in proportion to 4-FPBA loading. The degree to which PBA was bonded to chitosan was related to the 4-FPBA load used in the reaction (termed F1 through to F6 with increasing 4-FPBA load). Glucose adsorption sensitivity to PBA-bonded chitosan was directly related to the amount of PBA functionality within the conjugates and the physical nature of the matrices (porous or crystalline). Topographic analysis by SEM revealed that PBA-chitosan conjugates F1, F2 and F3 have porous matrices and their sensitivity to glucose adsorption was directly proportional to the degree of PBA substitution onto chitosan. Conversely, conjugates F4, F5 and F6 appeared crystalline under SEM and glucose adsorption sensitivity decreased in proportion to amount of PBA bonded to chitosan. The crystalline nature of the conjugates was confirmed by DSC, where the exothermic event related to the melting of the bonded PBA moiety, occurred at 338 °C. Thus, decreased sensitivity to glucose adsorption by the conjugates can be ascribed to the crystallinity imparted by increased content of the bonded PBA moiety, providing an optimal loading of PBA in terms of maximizing response to glucose.
Collapse
Affiliation(s)
- Yaa Asantewaa
- School of Pharmacy, The University of Nottingham, Malaysia Campus, Jalan Broga Semenyih 43500, Selangor Malaysia; E-Mail:
| | - Jonathan Aylott
- School of Pharmacy, The University of Nottingham, University Park Campus, NG7 2RD, UK; E-Mails: (J.A.); (J.C.B.); (C.J.R.)
| | - Jonathan C. Burley
- School of Pharmacy, The University of Nottingham, University Park Campus, NG7 2RD, UK; E-Mails: (J.A.); (J.C.B.); (C.J.R.)
| | - Nashiru Billa
- School of Pharmacy, The University of Nottingham, Malaysia Campus, Jalan Broga Semenyih 43500, Selangor Malaysia; E-Mail:
| | - Clive J. Roberts
- School of Pharmacy, The University of Nottingham, University Park Campus, NG7 2RD, UK; E-Mails: (J.A.); (J.C.B.); (C.J.R.)
| |
Collapse
|
42
|
Italian contributions to the development of continuous glucose monitoring sensors for diabetes management. SENSORS 2012. [PMID: 23202020 PMCID: PMC3545591 DOI: 10.3390/s121013753] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Abstract
Monitoring glucose concentration in the blood is essential in the therapy of diabetes, a pathology which affects about 350 million people around the World (three million in Italy), causes more than four million deaths per year and consumes a significant portion of the budget of national health systems (10% in Italy). In the last 15 years, several sensors with different degree of invasiveness have been proposed to monitor glycemia in a quasi-continuous way (up to 1 sample/min rate) for relatively long intervals (up to 7 consecutive days). These continuous glucose monitoring (CGM) sensors have opened new scenarios to assess, off-line, the effectiveness of individual patient therapeutic plans from the retrospective analysis of glucose time-series, but have also stimulated the development of innovative on-line applications, such as hypo/hyper-glycemia alert systems and artificial pancreas closed-loop control algorithms. In this review, we illustrate some significant Italian contributions, both from industry and academia, to the growth of the CGM sensors research area. In particular, technological, algorithmic and clinical developments performed in Italy will be discussed and put in relation with the advances obtained in the field in the wider international research community.
Collapse
|
43
|
Vashist SK. Non-invasive glucose monitoring technology in diabetes management: a review. Anal Chim Acta 2012; 750:16-27. [PMID: 23062426 DOI: 10.1016/j.aca.2012.03.043] [Citation(s) in RCA: 223] [Impact Index Per Article: 18.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2012] [Revised: 03/23/2012] [Accepted: 03/23/2012] [Indexed: 12/19/2022]
Abstract
The frequent monitoring of glucose is an essential part of diabetes management. Despite the fact that almost all the commercially successful blood glucose monitoring devices are invasive, there is an immense need to develop non-invasive glucose monitoring (NGM) devices that will alleviate the pain and suffering of diabetics associated with the frequent pricking of skin for taking the blood sample for glucose testing. There have been numerous developments in the field of NGM during the last decade, which stress the need for a critical review. This manuscript aims to review the various NGM techniques and devices. The challenges and future trends in NGM are also discussed.
Collapse
Affiliation(s)
- Sandeep Kumar Vashist
- NUS Nanosience and Nanotechnology Initiative NanoCore, National University of Singapore, T-Lab Level 11, 5A Engineering Drive 1, Singapore 117580, Singapore.
| |
Collapse
|
44
|
Anastasova S, Spehar-Délèze AM, Bickham D, Uebel P, Schmidt M, Russell P, Vadgama P. Stabilised Biosensing Using Needle-Based Recess Electrodes. ELECTROANAL 2011. [DOI: 10.1002/elan.201100511] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
45
|
Yan Q, Peng B, Su G, Cohan BE, Major TC, Meyerhoff ME. Measurement of tear glucose levels with amperometric glucose biosensor/capillary tube configuration. Anal Chem 2011; 83:8341-6. [PMID: 21961809 DOI: 10.1021/ac201700c] [Citation(s) in RCA: 102] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
An amperometric needle-type electrochemical glucose sensor intended for tear glucose measurements is described and employed in conjunction with a 0.84 mm i.d. capillary tube to collect microliter volumes of tear fluid. The sensor is based on immobilizing glucose oxidase on a 0.25 mm o.d. platinum/iridium (Pt/Ir) wire and anodically detecting the liberated hydrogen peroxide from the enzymatic reaction. Inner layers of Nafion and an electropolymerized film of 1,3-diaminobenzene/resorcinol greatly enhance the selectivity for glucose over potential interferences in tear fluid, including ascorbic acid and uric acid. Further, the new sensor is optimized to achieve very low detection limits of 1.5 ± 0.4 μM of glucose (S/N = 3) that is required to monitor glucose levels in tear fluid with a glucose sensitivity of 0.032 ± 0.02 nA/μM (n = 6). Only 4-5 μL of tear fluid in the capillary tube is required when the needle sensor is inserted into the capillary. The glucose sensor was employed to measure tear glucose levels in anesthetized rabbits over an 8 h period while also measuring the blood glucose values. A strong correlation between tear and blood glucose levels was found, suggesting that measurement of tear glucose is a potential noninvasive substitute for blood glucose measurements, and the new sensor configuration could aid in conducting further research in this direction.
Collapse
Affiliation(s)
- Qinyi Yan
- Department of Chemistry, The University of Michigan, Ann Arbor, Michigan 48109-1055, United States
| | | | | | | | | | | |
Collapse
|
46
|
Vaddiraju S, Burgess DJ, Tomazos I, Jain FC, Papadimitrakopoulos F. Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol 2010; 4:1540-62. [PMID: 21129353 PMCID: PMC3005068 DOI: 10.1177/193229681000400632] [Citation(s) in RCA: 152] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Devices for continuous glucose monitoring (CGM) are currently a major focus of research in the area of diabetes management. It is envisioned that such devices will have the ability to alert a diabetes patient (or the parent or medical care giver of a diabetes patient) of impending hypoglycemic/hyperglycemic events and thereby enable the patient to avoid extreme hypoglycemic/hyperglycemic excursions as well as minimize deviations outside the normal glucose range, thus preventing both life-threatening events and the debilitating complications associated with diabetes. It is anticipated that CGM devices will utilize constant feedback of analytical information from a glucose sensor to activate an insulin delivery pump, thereby ultimately realizing the concept of an artificial pancreas. Depending on whether the CGM device penetrates/breaks the skin and/or the sample is measured extracorporeally, these devices can be categorized as totally invasive, minimally invasive, and noninvasive. In addition, CGM devices are further classified according to the transduction mechanisms used for glucose sensing (i.e., electrochemical, optical, and piezoelectric). However, at present, most of these technologies are plagued by a variety of issues that affect their accuracy and long-term performance. This article presents a critical comparison of existing CGM technologies, highlighting critical issues of device accuracy, foreign body response, calibration, and miniaturization. An outlook on future developments with an emphasis on long-term reliability and performance is also presented.
Collapse
Affiliation(s)
- Santhisagar Vaddiraju
- Nanomaterials Optoelectronics Laboratory, Polymer Program, Institute of Materials Science, University of ConnecticutStorrs, Connecticut
- Biorasis Inc., Technology Incubation Program, University of ConnecticutStorrs, Connecticut
| | - Diane J Burgess
- Department of Pharmaceutical Sciences, University of ConnecticutStorrs, Connecticut
| | - Ioannis Tomazos
- Biorasis Inc., Technology Incubation Program, University of ConnecticutStorrs, Connecticut
| | - Faquir C Jain
- Nanomaterials Optoelectronics Laboratory, Polymer Program, Institute of Materials Science, University of ConnecticutStorrs, Connecticut
| | - Fotios Papadimitrakopoulos
- Nanomaterials Optoelectronics Laboratory, Polymer Program, Institute of Materials Science, University of ConnecticutStorrs, Connecticut
- Department of Chemistry, University of ConnecticutStorrs, Connecticut
| |
Collapse
|
47
|
Houston TA. Developing High-Affinity Boron-Based Receptors for Cell-Surface Carbohydrates. Chembiochem 2010; 11:954-7. [DOI: 10.1002/cbic.201000079] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
48
|
Abstract
Glucose monitoring technology has been used in the management of diabetes for three decades. Traditional devices use enzymatic methods to measure glucose concentration and provide point sample information. More recently continuous glucose monitoring devices have become available providing more detailed data on glucose excursions. In future applications the continuous glucose sensor may become a critical component of the closed loop insulin delivery system and, as such, must be selective, rapid, predictable and acceptable for continuous patient use. Many potential sensing modalities are being pursued including optical and transdermal techniques. This review aims to summarize existing technology, the methods for assessing glucose sensing devices and provide an overview of emergent sensing modalities.
Collapse
Affiliation(s)
- N S Oliver
- Institute of Biomedical Engineering, Imperial College, London, UK.
| | | | | | | |
Collapse
|
49
|
Levonis SM, Kiefel MJ, Houston TA. Boronolectin with divergent fluorescent response specific for free sialic acid. Chem Commun (Camb) 2009:2278-80. [DOI: 10.1039/b900836p] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
50
|
Bai C, Graham TL, Arnold MA. Assessing and Advancing Technology for the Noninvasive Measurement of Clinical Glucose. ANAL LETT 2008. [DOI: 10.1080/00032710802418885] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|